European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - busulfan - hematopoietic stem cell transplantation - alkyl sulfonates - busulfan fresenius kabi followed by cyclophosphamide (bucy2) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation (hpct) in adult patients when the combination is considered the best available option.busulfan fresenius kabi followed by cyclophosphamide (bucy4) or melphalan (bumel) is indicated as conditioning treatment prior to conventional haematopoietic progenitor cell transplantation in paediatric patients.

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - pemetrexed - carcinoma, non-small-cell lung; mesothelioma - antineoplastic agents - malignant pleural mesotheliomapemetrexed fresenius kabi in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.non-small cell lung cancerpemetrexed fresenius kabi in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.pemetrexed fresenius kabi is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed fresenius kabi is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - caspofungin - pdr/conc/soln for infus - 50 milligram - other mycotics for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - caspofungin - pdr/conc/soln for infus - 70 milligram - other mycotics for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - soya bean oil, refined; methionine; tryptophan; olive oil, refined; phenylalanine; triglycerides medium-chain; proline; isoleucine; alanine; tyrosine; serine; arginine; glucose monohydrate; taurine; glycine; valine; lysine acetate; fish oil, rich in omega-3 acids; leucine; histidine - emulsion for infusion - unknown - solutions for parenteral nutrition; combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - soybean oil ; glucose anhydrous ; alanine ; arginine ; aspartic acid ; glutamic acid ; glycine; histidine ; isoleucine ; leucine ; lysine ; methionine; phenylalanine ; proline ; serine ; threonine ; tryptophan, l- ; tyrosine ; valine ; calcium chloride dihydrate ; sodium glycerophosphate anhydrous ; potassium chloride; sodium acetate - emulsion for infusion - %w/v - combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - soya bean oil; glucose anhydrous; alanine; arginine; aspartic acid; glutamic acid; glycine; histidine; isoleucine; leucine; lysine; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine; valine; calcium chloride; sodium glycerophosphate anhydrous; magnesium sulfate; potassium chloride; sodium acetate - emulsion for infusion - percent weight/volume - solutions for parenteral nutrition; combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - soya bean oil, refined; calcium chloride dihydrate; methionine; potassium chloride; tryptophan; olive oil, refined; zinc sulphate heptahydrate; phenylalanine; triglycerides medium-chain; proline; isoleucine; magnesium sulfate heptahydrate; alanine; tyrosine; sodium acetate trihydrate; serine; sodium glycerophophate hydrate; arginine; glucose monohydrate; taurine; glycine; valine; lysine acetate; fish oil, rich in omega-3 acids; leucine; histidine - emulsion for infusion - unknown - solutions for parenteral nutrition; combinations

European Union - English - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuscular blockade - all other therapeutic products - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - l-alanine; l-arginine; glycine; l-histidine; l-isoleucine; l-leucine; l-lysine; l-methionine; l-phenylalanine; l-proline; l-serine; taurine; l-threonine; l-tryptophan; l-tyrosine; l-valine; calcium chloride; sodium glycerophophate hydrate; magnesium sulphate heptahydrate; potassium chloride; sodium acetate trihydrate; zinc sulphate heptahydrate; glucose monohydrate; soya bean oil, refined; triglycerides, medium chain; olive oil, refined; fish oil, rich in omega-3 acids - emulsion for infusion - 0 gram(s) - solutions for parenteral nutrition; combinations